Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > February 24, 2023
Daily News
February 24, 2023
- Ono Bags Right to Cue Biopharma’s Tregs-Inducing Bispecific Protein
February 24, 2023
- OB/GYN Group Urges MHLW to Facilitate Access to Oral Abortion Drug
February 24, 2023
- Probe Panel Recognizes Professor’s COI over Glactiv Scandal, but Doubts Whether It Constitutes Bribery
February 24, 2023
- Shionogi’s Xocova Cuts Risks of Long COVID by 45%: Exploratory Data
February 24, 2023
- Japan Panel OKs Plan to Offer 2 Boosters for Elderly in FY2023; Program to Start from May
February 24, 2023
- Opdivo Approved for NSCLC Neoadjuvant Use in Taiwan
February 24, 2023
- Alexion’s Danicopan, Pfizer’s Elranatamab and 2 More APIs Get Orphan Tag
February 24, 2023
- Nipro Pharma Likely to Face Business Improvement Order over Violations
February 24, 2023
- Why Market Mapping Is Critical to Your Organization
February 24, 2023
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…